img

Global Dendritic Cell Therapy Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dendritic Cell Therapy Vaccine Market Research Report 2024

Dendritic cells are antigen-presenting cells found in lymphoid organs, their primary role is to activate T cells and display antigens. Antigen display aids in pathogen and microbe recognition by T-cells, allowing for their eradication and identification from the body. These cells aid in the capture and processing of tumor antigens, resulting in the activation of lymphocyte co-stimulatory molecules and the production of cytokines to trigger the immune response.
According to Mr Accuracy reports’s new survey, global Dendritic Cell Therapy Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dendritic Cell Therapy Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dendritic Cell Therapy Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Argos Therapeutics
JW Creagene
DanDrit Biotech
DCPrime
Elios Therapeutics Inc
ImmunoCellular Therapeutics Ltd
Immunicum AB
Tella Inc
Northwest Biotherapeutics Inc
Glaxo plc
Segment by Type
Intravenous Injection
Subcutaneous Injection
Intratumoral Injection

Segment by Application


Lung Cancer
Prostatic Cancer
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dendritic Cell Therapy Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dendritic Cell Therapy Vaccine Market Overview
1.1 Product Overview and Scope of Dendritic Cell Therapy Vaccine
1.2 Dendritic Cell Therapy Vaccine Segment by Type
1.2.1 Global Dendritic Cell Therapy Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Intravenous Injection
1.2.3 Subcutaneous Injection
1.2.4 Intratumoral Injection
1.3 Dendritic Cell Therapy Vaccine Segment by Application
1.3.1 Global Dendritic Cell Therapy Vaccine Market Value by Application: (2024-2034)
1.3.2 Lung Cancer
1.3.3 Prostatic Cancer
1.3.4 Other
1.4 Global Dendritic Cell Therapy Vaccine Market Size Estimates and Forecasts
1.4.1 Global Dendritic Cell Therapy Vaccine Revenue 2018-2029
1.4.2 Global Dendritic Cell Therapy Vaccine Sales 2018-2029
1.4.3 Global Dendritic Cell Therapy Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dendritic Cell Therapy Vaccine Market Competition by Manufacturers
2.1 Global Dendritic Cell Therapy Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Dendritic Cell Therapy Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Dendritic Cell Therapy Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Dendritic Cell Therapy Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Dendritic Cell Therapy Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dendritic Cell Therapy Vaccine, Product Type & Application
2.7 Dendritic Cell Therapy Vaccine Market Competitive Situation and Trends
2.7.1 Dendritic Cell Therapy Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dendritic Cell Therapy Vaccine Players Market Share by Revenue
2.7.3 Global Dendritic Cell Therapy Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dendritic Cell Therapy Vaccine Retrospective Market Scenario by Region
3.1 Global Dendritic Cell Therapy Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dendritic Cell Therapy Vaccine Global Dendritic Cell Therapy Vaccine Sales by Region: 2018-2029
3.2.1 Global Dendritic Cell Therapy Vaccine Sales by Region: 2018-2024
3.2.2 Global Dendritic Cell Therapy Vaccine Sales by Region: 2024-2029
3.3 Global Dendritic Cell Therapy Vaccine Global Dendritic Cell Therapy Vaccine Revenue by Region: 2018-2029
3.3.1 Global Dendritic Cell Therapy Vaccine Revenue by Region: 2018-2024
3.3.2 Global Dendritic Cell Therapy Vaccine Revenue by Region: 2024-2029
3.4 North America Dendritic Cell Therapy Vaccine Market Facts & Figures by Country
3.4.1 North America Dendritic Cell Therapy Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dendritic Cell Therapy Vaccine Sales by Country (2018-2029)
3.4.3 North America Dendritic Cell Therapy Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dendritic Cell Therapy Vaccine Market Facts & Figures by Country
3.5.1 Europe Dendritic Cell Therapy Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dendritic Cell Therapy Vaccine Sales by Country (2018-2029)
3.5.3 Europe Dendritic Cell Therapy Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dendritic Cell Therapy Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Dendritic Cell Therapy Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dendritic Cell Therapy Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Dendritic Cell Therapy Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dendritic Cell Therapy Vaccine Market Facts & Figures by Country
3.7.1 Latin America Dendritic Cell Therapy Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dendritic Cell Therapy Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Dendritic Cell Therapy Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dendritic Cell Therapy Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dendritic Cell Therapy Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dendritic Cell Therapy Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dendritic Cell Therapy Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dendritic Cell Therapy Vaccine Sales by Type (2018-2029)
4.1.1 Global Dendritic Cell Therapy Vaccine Sales by Type (2018-2024)
4.1.2 Global Dendritic Cell Therapy Vaccine Sales by Type (2024-2029)
4.1.3 Global Dendritic Cell Therapy Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Dendritic Cell Therapy Vaccine Revenue by Type (2018-2029)
4.2.1 Global Dendritic Cell Therapy Vaccine Revenue by Type (2018-2024)
4.2.2 Global Dendritic Cell Therapy Vaccine Revenue by Type (2024-2029)
4.2.3 Global Dendritic Cell Therapy Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Dendritic Cell Therapy Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dendritic Cell Therapy Vaccine Sales by Application (2018-2029)
5.1.1 Global Dendritic Cell Therapy Vaccine Sales by Application (2018-2024)
5.1.2 Global Dendritic Cell Therapy Vaccine Sales by Application (2024-2029)
5.1.3 Global Dendritic Cell Therapy Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Dendritic Cell Therapy Vaccine Revenue by Application (2018-2029)
5.2.1 Global Dendritic Cell Therapy Vaccine Revenue by Application (2018-2024)
5.2.2 Global Dendritic Cell Therapy Vaccine Revenue by Application (2024-2029)
5.2.3 Global Dendritic Cell Therapy Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Dendritic Cell Therapy Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Argos Therapeutics
6.1.1 Argos Therapeutics Corporation Information
6.1.2 Argos Therapeutics Description and Business Overview
6.1.3 Argos Therapeutics Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Argos Therapeutics Dendritic Cell Therapy Vaccine Product Portfolio
6.1.5 Argos Therapeutics Recent Developments/Updates
6.2 JW Creagene
6.2.1 JW Creagene Corporation Information
6.2.2 JW Creagene Description and Business Overview
6.2.3 JW Creagene Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 JW Creagene Dendritic Cell Therapy Vaccine Product Portfolio
6.2.5 JW Creagene Recent Developments/Updates
6.3 DanDrit Biotech
6.3.1 DanDrit Biotech Corporation Information
6.3.2 DanDrit Biotech Description and Business Overview
6.3.3 DanDrit Biotech Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 DanDrit Biotech Dendritic Cell Therapy Vaccine Product Portfolio
6.3.5 DanDrit Biotech Recent Developments/Updates
6.4 DCPrime
6.4.1 DCPrime Corporation Information
6.4.2 DCPrime Description and Business Overview
6.4.3 DCPrime Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 DCPrime Dendritic Cell Therapy Vaccine Product Portfolio
6.4.5 DCPrime Recent Developments/Updates
6.5 Elios Therapeutics Inc
6.5.1 Elios Therapeutics Inc Corporation Information
6.5.2 Elios Therapeutics Inc Description and Business Overview
6.5.3 Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Product Portfolio
6.5.5 Elios Therapeutics Inc Recent Developments/Updates
6.6 ImmunoCellular Therapeutics Ltd
6.6.1 ImmunoCellular Therapeutics Ltd Corporation Information
6.6.2 ImmunoCellular Therapeutics Ltd Description and Business Overview
6.6.3 ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Product Portfolio
6.6.5 ImmunoCellular Therapeutics Ltd Recent Developments/Updates
6.7 Immunicum AB
6.6.1 Immunicum AB Corporation Information
6.6.2 Immunicum AB Description and Business Overview
6.6.3 Immunicum AB Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Immunicum AB Dendritic Cell Therapy Vaccine Product Portfolio
6.7.5 Immunicum AB Recent Developments/Updates
6.8 Tella Inc
6.8.1 Tella Inc Corporation Information
6.8.2 Tella Inc Description and Business Overview
6.8.3 Tella Inc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Tella Inc Dendritic Cell Therapy Vaccine Product Portfolio
6.8.5 Tella Inc Recent Developments/Updates
6.9 Northwest Biotherapeutics Inc
6.9.1 Northwest Biotherapeutics Inc Corporation Information
6.9.2 Northwest Biotherapeutics Inc Description and Business Overview
6.9.3 Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Product Portfolio
6.9.5 Northwest Biotherapeutics Inc Recent Developments/Updates
6.10 Glaxo plc
6.10.1 Glaxo plc Corporation Information
6.10.2 Glaxo plc Description and Business Overview
6.10.3 Glaxo plc Dendritic Cell Therapy Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Glaxo plc Dendritic Cell Therapy Vaccine Product Portfolio
6.10.5 Glaxo plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dendritic Cell Therapy Vaccine Industry Chain Analysis
7.2 Dendritic Cell Therapy Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dendritic Cell Therapy Vaccine Production Mode & Process
7.4 Dendritic Cell Therapy Vaccine Sales and Marketing
7.4.1 Dendritic Cell Therapy Vaccine Sales Channels
7.4.2 Dendritic Cell Therapy Vaccine Distributors
7.5 Dendritic Cell Therapy Vaccine Customers
8 Dendritic Cell Therapy Vaccine Market Dynamics
8.1 Dendritic Cell Therapy Vaccine Industry Trends
8.2 Dendritic Cell Therapy Vaccine Market Drivers
8.3 Dendritic Cell Therapy Vaccine Market Challenges
8.4 Dendritic Cell Therapy Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dendritic Cell Therapy Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dendritic Cell Therapy Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dendritic Cell Therapy Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Dendritic Cell Therapy Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Dendritic Cell Therapy Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Dendritic Cell Therapy Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Dendritic Cell Therapy Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Dendritic Cell Therapy Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Dendritic Cell Therapy Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Dendritic Cell Therapy Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dendritic Cell Therapy Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Dendritic Cell Therapy Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dendritic Cell Therapy Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Therapy Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dendritic Cell Therapy Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Dendritic Cell Therapy Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Dendritic Cell Therapy Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Dendritic Cell Therapy Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Dendritic Cell Therapy Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Dendritic Cell Therapy Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Dendritic Cell Therapy Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Dendritic Cell Therapy Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Dendritic Cell Therapy Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Dendritic Cell Therapy Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Dendritic Cell Therapy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Dendritic Cell Therapy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Dendritic Cell Therapy Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Dendritic Cell Therapy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Dendritic Cell Therapy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Dendritic Cell Therapy Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Dendritic Cell Therapy Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Dendritic Cell Therapy Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Dendritic Cell Therapy Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Dendritic Cell Therapy Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Dendritic Cell Therapy Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Dendritic Cell Therapy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Dendritic Cell Therapy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Dendritic Cell Therapy Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Dendritic Cell Therapy Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Dendritic Cell Therapy Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Dendritic Cell Therapy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Dendritic Cell Therapy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Dendritic Cell Therapy Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Dendritic Cell Therapy Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Dendritic Cell Therapy Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Dendritic Cell Therapy Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Dendritic Cell Therapy Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Dendritic Cell Therapy Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Dendritic Cell Therapy Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Dendritic Cell Therapy Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Dendritic Cell Therapy Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Dendritic Cell Therapy Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Dendritic Cell Therapy Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Dendritic Cell Therapy Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Dendritic Cell Therapy Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Dendritic Cell Therapy Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Dendritic Cell Therapy Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Dendritic Cell Therapy Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Dendritic Cell Therapy Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Dendritic Cell Therapy Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Dendritic Cell Therapy Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Dendritic Cell Therapy Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Argos Therapeutics Corporation Information
Table 71. Argos Therapeutics Description and Business Overview
Table 72. Argos Therapeutics Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Argos Therapeutics Dendritic Cell Therapy Vaccine Product
Table 74. Argos Therapeutics Recent Developments/Updates
Table 75. JW Creagene Corporation Information
Table 76. JW Creagene Description and Business Overview
Table 77. JW Creagene Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. JW Creagene Dendritic Cell Therapy Vaccine Product
Table 79. JW Creagene Recent Developments/Updates
Table 80. DanDrit Biotech Corporation Information
Table 81. DanDrit Biotech Description and Business Overview
Table 82. DanDrit Biotech Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. DanDrit Biotech Dendritic Cell Therapy Vaccine Product
Table 84. DanDrit Biotech Recent Developments/Updates
Table 85. DCPrime Corporation Information
Table 86. DCPrime Description and Business Overview
Table 87. DCPrime Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. DCPrime Dendritic Cell Therapy Vaccine Product
Table 89. DCPrime Recent Developments/Updates
Table 90. Elios Therapeutics Inc Corporation Information
Table 91. Elios Therapeutics Inc Description and Business Overview
Table 92. Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Elios Therapeutics Inc Dendritic Cell Therapy Vaccine Product
Table 94. Elios Therapeutics Inc Recent Developments/Updates
Table 95. ImmunoCellular Therapeutics Ltd Corporation Information
Table 96. ImmunoCellular Therapeutics Ltd Description and Business Overview
Table 97. ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. ImmunoCellular Therapeutics Ltd Dendritic Cell Therapy Vaccine Product
Table 99. ImmunoCellular Therapeutics Ltd Recent Developments/Updates
Table 100. Immunicum AB Corporation Information
Table 101. Immunicum AB Description and Business Overview
Table 102. Immunicum AB Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Immunicum AB Dendritic Cell Therapy Vaccine Product
Table 104. Immunicum AB Recent Developments/Updates
Table 105. Tella Inc Corporation Information
Table 106. Tella Inc Description and Business Overview
Table 107. Tella Inc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Tella Inc Dendritic Cell Therapy Vaccine Product
Table 109. Tella Inc Recent Developments/Updates
Table 110. Northwest Biotherapeutics Inc Corporation Information
Table 111. Northwest Biotherapeutics Inc Description and Business Overview
Table 112. Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Northwest Biotherapeutics Inc Dendritic Cell Therapy Vaccine Product
Table 114. Northwest Biotherapeutics Inc Recent Developments/Updates
Table 115. Glaxo plc Corporation Information
Table 116. Glaxo plc Description and Business Overview
Table 117. Glaxo plc Dendritic Cell Therapy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Glaxo plc Dendritic Cell Therapy Vaccine Product
Table 119. Glaxo plc Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Dendritic Cell Therapy Vaccine Distributors List
Table 123. Dendritic Cell Therapy Vaccine Customers List
Table 124. Dendritic Cell Therapy Vaccine Market Trends
Table 125. Dendritic Cell Therapy Vaccine Market Drivers
Table 126. Dendritic Cell Therapy Vaccine Market Challenges
Table 127. Dendritic Cell Therapy Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dendritic Cell Therapy Vaccine
Figure 2. Global Dendritic Cell Therapy Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dendritic Cell Therapy Vaccine Market Share by Type in 2022 & 2029
Figure 4. Intravenous Injection Product Picture
Figure 5. Subcutaneous Injection Product Picture
Figure 6. Intratumoral Injection Product Picture
Figure 7. Global Dendritic Cell Therapy Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Dendritic Cell Therapy Vaccine Market Share by Application in 2022 & 2029
Figure 9. Lung Cancer
Figure 10. Prostatic Cancer
Figure 11. Other
Figure 12. Global Dendritic Cell Therapy Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dendritic Cell Therapy Vaccine Market Size (2018-2029) & (US$ Million)
Figure 14. Global Dendritic Cell Therapy Vaccine Sales (2018-2029) & (K Units)
Figure 15. Global Dendritic Cell Therapy Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 16. Dendritic Cell Therapy Vaccine Report Years Considered
Figure 17. Dendritic Cell Therapy Vaccine Sales Share by Manufacturers in 2022
Figure 18. Global Dendritic Cell Therapy Vaccine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Dendritic Cell Therapy Vaccine Players: Market Share by Revenue in 2022
Figure 20. Dendritic Cell Therapy Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Dendritic Cell Therapy Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Dendritic Cell Therapy Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Dendritic Cell Therapy Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. United States Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Dendritic Cell Therapy Vaccine Sales Market Share by Country (2018-2029)
Figure 27. Europe Dendritic Cell Therapy Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. Germany Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Dendritic Cell Therapy Vaccine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Dendritic Cell Therapy Vaccine Revenue Market Share by Region (2018-2029)
Figure 35. China Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Dendritic Cell Therapy Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Dendritic Cell Therapy Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Dendritic Cell Therapy Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Dendritic Cell Therapy Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Dendritic Cell Therapy Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Dendritic Cell Therapy Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Dendritic Cell Therapy Vaccine by Type (2018-2029)
Figure 54. Global Dendritic Cell Therapy Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Dendritic Cell Therapy Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Dendritic Cell Therapy Vaccine by Application (2018-2029)
Figure 57. Global Dendritic Cell Therapy Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Dendritic Cell Therapy Vaccine Value Chain
Figure 59. Dendritic Cell Therapy Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries